Reata Pharmaceuticals Employees 2024

Reata Pharmaceuticals Aktienanalyse

What does Reata Pharmaceuticals do?

Reata Pharmaceuticals Inc is a biopharmaceutical company that was founded in Irving, Texas in 2002. The company develops and markets innovative therapeutics for severe and rare diseases, particularly rare genetic metabolic diseases, neurological diseases, and inflammatory diseases. Reata Pharmaceuticals has a unique business model based on the principle of "platform technology". This means that the company develops various therapeutic approaches based on a patented molecular platform. This platform allows Reata to quickly and efficiently develop new products for different disease areas. An important focus of Reata Pharmaceuticals' activities is the development of therapeutics for rare genetic metabolic diseases. The company has made remarkable progress in this area. In particular, the drug Omaveloxolone, which was developed for the treatment of Friedreich's ataxia, has attracted a lot of attention. This rare disease manifests as progressive spastic paralysis and can eventually lead to death. The drug has shown promising results in a Phase 2 study and is currently in Phase 3 study. Another important area for Reata Pharmaceuticals is inflammatory diseases. The company has developed a product called Bardoxolone Methyl, which is approved for the treatment of chronic kidney disease and pulmonary hypertension. These diseases have a significant impact on the quality of life and life expectancy of patients. Bardoxolone Methyl has shown in clinical studies that it can slow disease progression and significantly improve symptoms. In addition to these two pillars of activity, Reata Pharmaceuticals also has various product candidates for neurological diseases, cancer, and other diseases in the pipeline. The company aims to develop innovative solutions for unmet medical needs and help patients whose needs have not been adequately addressed. The history of Reata Pharmaceuticals is characterized by a successful path as a company with a unique business model. The company aims to play a leading role in the development and marketing of therapeutics for rare and serious diseases. To achieve this, the company has built a strong research and development team and works closely with the academic community. Reata Pharmaceuticals has managed to establish an international network of leading scientists, doctors, and patient organizations. This collaboration is crucial for the successful development and marketing of therapeutics for rare diseases. In summary, Reata Pharmaceuticals Inc is an innovative biopharmaceutical company that uses a unique platform technology for the development of therapeutics for rare and severe diseases. The company has made remarkable progress in the development of therapeutics for rare genetic metabolic diseases and inflammatory diseases and is working on additional products for neurological diseases, cancer, and other diseases. Reata Pharmaceuticals aims to play a leading role in the industry and help patients whose needs have not been adequately addressed. Reata Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Reata Pharmaceuticals's Employee Base

Reata Pharmaceuticals's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Reata Pharmaceuticals's operational capacity and future potential.

Year-to-Year Comparison

Assessing Reata Pharmaceuticals's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Reata Pharmaceuticals's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Reata Pharmaceuticals’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Reata Pharmaceuticals Stock

How many employees does Reata Pharmaceuticals have this year?

Reata Pharmaceuticals has 261 undefined employees this year.

How many employees did Reata Pharmaceuticals have compared to the previous year?

Compared to the previous year, Reata Pharmaceuticals had 0% more employees.

What impact did the number of employees have on the company Reata Pharmaceuticals?

The number of employees has a direct impact on the efficiency and productivity of Reata Pharmaceuticals. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Reata Pharmaceuticals?

The number of employees can also have an impact on investors of Reata Pharmaceuticals, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Reata Pharmaceuticals affect the company?

An increase in equity of Reata Pharmaceuticals can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Reata Pharmaceuticals's equity affect the company?

A reduction in equity of Reata Pharmaceuticals can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Reata Pharmaceuticals?

Some factors that can influence the equity of Reata Pharmaceuticals include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Reata Pharmaceuticals so important for investors?

The equity of Reata Pharmaceuticals is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Reata Pharmaceuticals influence the company?

The number of employees at Reata Pharmaceuticals can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Reata Pharmaceuticals evolved in recent years?

In recent years, the number of employees at Reata Pharmaceuticals has changed by 0.

How many employees does Reata Pharmaceuticals currently have?

Reata Pharmaceuticals currently has 261 undefined employees.

Why is the number of employees important for investors of Reata Pharmaceuticals?

The number of employees is important for investors of Reata Pharmaceuticals as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Reata Pharmaceuticals take to change the number of employees?

To change the number of employees, Reata Pharmaceuticals can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Reata Pharmaceuticals pay?

Over the past 12 months, Reata Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Reata Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Reata Pharmaceuticals?

The current dividend yield of Reata Pharmaceuticals is .

When does Reata Pharmaceuticals pay dividends?

Reata Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Reata Pharmaceuticals?

Reata Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Reata Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Reata Pharmaceuticals located?

Reata Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Reata Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Reata Pharmaceuticals from 5/28/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/28/2024.

When did Reata Pharmaceuticals pay the last dividend?

The last dividend was paid out on 5/28/2024.

What was the dividend of Reata Pharmaceuticals in the year 2023?

In the year 2023, Reata Pharmaceuticals distributed 0 USD as dividends.

In which currency does Reata Pharmaceuticals pay out the dividend?

The dividends of Reata Pharmaceuticals are distributed in USD.